Patents Represented by Attorney, Agent or Law Firm Michael D. Yablonsku
  • Rotavirus vaccine formulations
    Patent number: 6403098
    Abstract: The present invention provides novel liquid and lyophilized formulations of vaccines against rotavirus infection and methods of their preparation. The formulations include buffering agents appropriate for oral administration of rotavirus vaccines. The formulations also include compounds to stabilize of the vaccine compositions against loss of potency.
    Type: Grant
    Filed: August 3, 1999
    Date of Patent: June 11, 2002
    Assignee: Merck & Co., Inc.
    Inventors: Carl J. Burke, David B. Volkin